INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H901. A total of 4 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $361,452 | +51.9% | 231,700 | +67.7% | 0.00% | – |
Q3 2022 | $238,000 | +19.0% | 138,200 | +147.7% | 0.00% | – |
Q1 2022 | $200,000 | -86.6% | 55,800 | -81.4% | 0.00% | -100.0% |
Q4 2021 | $1,496,000 | -54.9% | 299,700 | -16.2% | 0.00% | -75.0% |
Q2 2021 | $3,316,000 | -29.0% | 357,700 | -28.9% | 0.00% | -42.9% |
Q1 2021 | $4,668,000 | +7.1% | 503,000 | +2.1% | 0.01% | +16.7% |
Q4 2020 | $4,360,000 | -47.0% | 492,600 | -30.6% | 0.01% | -53.8% |
Q3 2020 | $8,230,000 | -7.5% | 709,500 | +114.9% | 0.01% | -27.8% |
Q2 2020 | $8,899,000 | – | 330,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 348,400 | $3,219,000 | 0.04% |
SIMPLEX TRADING, LLC | 980 | $143,000 | 0.01% |
Citadel Advisors | 33,600 | $310,000 | 0.00% |